Succinylcholine Infusion: Not Recommended for Routine Use
Succinylcholine infusion is generally not recommended in modern practice due to significant risks of Phase II block, prolonged paralysis, and life-threatening complications—use intermittent bolus dosing or alternative non-depolarizing agents instead. 1
Why Infusions Are Problematic
Continuous succinylcholine infusion carries substantial risks that outweigh potential benefits:
- Phase II block development: Occurs unpredictably, often after 50-90 minutes of infusion, converting from depolarizing to non-depolarizing blockade 2, 3
- Tachyphylaxis: Develops in approximately 25% of patients, requiring progressively higher doses 3
- Unpredictable recovery: 50% of patients with Phase II block experience prolonged recovery requiring reversal 3
- Hyperkalemia risk: Continuous exposure increases risk of life-threatening potassium release, especially in ICU patients 4
If Infusion Must Be Used (Long Procedures)
Dosing Parameters
- Concentration: Prepare 1 mg/mL solution (preferred for precise titration) 1
- Infusion rate: 2.5-4.3 mg/min for adults (average ~83.5 mcg/kg/min) 1, 5
- Adjust to maintain 5-10% of baseline twitch height
- Range: 0.5-10 mg/min depending on individual response
Mandatory Monitoring
Neuromuscular monitoring with peripheral nerve stimulator is absolutely required to:
- Avoid overdose
- Detect Phase II block development (train-of-four ratio <0.5)
- Guide recovery assessment
- Determine need for reversal 1
Duration Considerations
- <90 minutes: Lower risk but Phase II block still possible 2
- >90 minutes: High probability of Phase II block and tachyphylaxis 2, 3
- After infusion stops, therapeutic plasma levels persist ~6 hours 6
Critical Contraindications
Absolute contraindications (life-threatening hyperkalemia risk):
- Malignant hyperthermia history
- Severe burns/crush injury (>24 hours post-injury)
- Spinal cord injury
- Neuromuscular disease/myopathy
- Prolonged immobilization/bedridden patients
- Chronic renal failure
- Receptor upregulation states 7, 8, 4
ICU patients have 70.9% prevalence of contraindications, with 11.3% at high risk for hyperkalemic complications 4. In this population, succinylcholine use is strongly discouraged.
Safer Alternative Approach
For Long Procedures
Use intermittent bolus technique instead:
- Initial dose: 0.3-1.1 mg/kg IV
- Maintenance: 0.04-0.07 mg/kg at appropriate intervals
- Provides better control and predictability 1
Or Switch to Non-Depolarizing Agents
- Rocuronium: 0.1 mg/kg for maintenance (duration 45-90 min) 7
- Cisatracurium: Preferred in renal failure, pregnancy (Category B)
- Allows reversal with sugammadex if needed
Preparation and Administration
Solution Preparation
- Add 1g succinylcholine to 1000 mL sterile solution (D5W or NS) for 1 mg/mL concentration
- Use within 24 hours of preparation
- Single patient use only—discard unused portions
- Do NOT mix with alkaline solutions (pH >8.5) 1
Essential Precautions
- Atropine pretreatment: 0.02 mg/kg (min 0.1 mg, max 1 mg) to prevent bradycardia/asystole 7
- Airway equipment: Must be immediately available with skilled personnel present
- Ventilatory support: Mandatory throughout infusion
- Avoid fluid overload: Use concentrated solutions when possible 1
Recovery and Reversal
Expected Recovery
- Phase I block: 5-10 minutes after stopping infusion 7
- Phase II block: Highly variable, may require 30+ minutes 3
When to Reverse
If Phase II block develops (train-of-four ratio <0.5) and spontaneous recovery is inadequate after 30 minutes:
- Neostigmine 0.04-0.07 mg/kg + atropine 0.02 mg/kg
- Successful reversal achieved in all reported cases 2, 3
Bottom Line
The unpredictability of Phase II block, risk of prolonged paralysis, and high prevalence of contraindications make succinylcholine infusion obsolete in contemporary practice. Use single bolus dosing for intubation, then switch to non-depolarizing agents for maintenance paralysis. If infusion is absolutely necessary, mandatory neuromuscular monitoring and immediate availability of reversal agents are non-negotiable requirements.